Integer Holdings Corporation (WGB)
XFRA 
Summary
WGB Chart
Integer Holdings 2026 Outlook: Drivers, Risks, Valuation
ITGR resets its 2026 outlook after customer forecast changes and slower product ramps, with growth and margin recovery tied to adoption timing.
Integer Holdings: Rare Public Asset Soon To Be Sold
Integer Holdings Corp. is a unique, high-quality medical device CDMO trading at a depressed ~10x EBITDA multiple after a temporary growth slowdown. A strategic review, prompted by activist involvement and heightened buyer interest, positions ITGR for a likely sale within three to four months. Precedent CDMO transactions support a fair value of $110–125/share (13–14x forward EBITDA), offering 20–40% upside with limited downside risk.
Integer Holdings Corporation (ITGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Integer Holdings Corporation (ITGR) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Integer Holdings Corporation (WGB) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Integer Holdings Corporation ever had a stock split?
Integer Holdings Corporation Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Payman Khales CEO | XFRA Exchange | 45826H109 CUSIP |
| US Country | 11,000 Employees | - Last Dividend | - Last Split | 29 Sep 2000 IPO Date |
Overview
Integer Holdings Corporation is a leading medical device outsource manufacturer offering a wide range of products and services across the globe, including the United States, Puerto Rico, Costa Rica, and other international markets. The company, founded in 1970 and headquartered in Plano, Texas, operates through two primary segments: Medical and Non-Medical. It caters to the needs of multi-national original equipment manufacturers (OEMs) and their affiliated subsidiaries, particularly in the areas of cardiac rhythm management, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical markets. Integer Holdings Corporation's offerings are essential in a variety of medical procedures such as interventional cardiology, electrophysiology, and surgeries involving orthopedics, offering cutting-edge solutions that enhance patient care and outcomes.
Products and Services
Integer Holdings Corporation provides a diverse portfolio of products and services across various medical fields:
- Cardiovascular and Cardiac Rhythm Management: Products include implantable pacemakers, cardioverter defibrillators, insertable cardiac monitors, pacing and defibrillation leads, heart failure therapies, and more, catering to interventional cardiology and structural heart procedures.
- Neuromodulation: Offers implantable spinal cord stimulators for managing chronic pain and other conditions through neurostimulation.
- Vascular Access and Peripheral Vascular: Provides solutions for hemodialysis, infusion therapy, and peripheral vascular interventions, improving patient outcomes in these critical areas.
- Non-Vascular Interventions: Supplies products for urology, gastroenterology, and non-vascular procedures, ensuring a broad coverage of medical needs.
- Energy Solutions: Offers customized battery power and management systems for medical devices, alongside battery solutions for the energy, military, and environmental markets, highlighting the company's expertise beyond the medical field.
- Surgical Instruments and Components: Supplies a variety of devices and components for general surgery, orthopedics, laparoscopic, and arthroscopic procedures, including harmonic scalpels, shaver blades, biopsy probes, and instruments used in hip, knee, and spine surgeries.
- Advanced Surgical and Portable Medical Devices: Provides cutting-edge products for advanced surgical procedures and portable medical devices, such as wound dressings, GERD treatment components, and phacoemulsification needles, proving Integer's commitment to innovation in surgery and patient care.
